Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
NPJ Precision Oncology|June 7, 2018
Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinomaMy Linh Thibodeau, Melika Bonakdar, Eric Zhao, et al.Cold Spring Harbor Molecular Case Studies|November 3, 2017
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencingHui-Li Wong, Kevin C Yang, Yaoqing Shen, et al.The Lancet. Oncology|April 17, 2016
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialKeunchil Park, Eng-Huat Tan, Ken O'Byrne, et al.Future Oncology (London, England)|January 19, 2023
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS dataParneet Cheema, Byoung Chul Cho, Helano Freitas, et al.JCO Precision Oncology|August 3, 2019
Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed CancerYulia Newton, S Rod Rassekh, Rebecca J Deyell, et al.Cold Spring Harbor Molecular Case Studies|May 18, 2017
Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinomaMy Linh Thibodeau, Caralyn Reisle, Eric Zhao, et al.Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic CancerJoanna M Karasinska, James T Topham, Steve E Kalloger, et al.NPJ Precision Oncology|December 21, 2021
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyuryLaura M Williamson, Craig M Rive, Daniela Di Francesco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2020
Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid TumorsAlexandra Pender, Emma Titmuss, Erin D Pleasance, et al.Pageof 12